Impact of co-morbidities on self-rated health in self-reported COPD: An analysis of NHANES 2001-2008

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 3, 2013, Pages 324-332

  Putcha, Nirupama ^a   Puhan, Milo A ^b   Hansel, Nadia N ^a   Drummond, M Brad ^a   Boyd, Cynthia M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Multi morbidity; National survey; Patient reported outcomes; Quality of life

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DEPRESSION; DIABETES MELLITUS; FEMALE; HEALTH STATUS; HUMAN; INCONTINENCE; MALE; OBESITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE DISEASE; SELF REPORT; SMOKING;

AGED; ARTHRITIS; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH STATUS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; PROSTATIC DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF REPORT; URINARY INCONTINENCE;

EID: 84878498314     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.744963     Document Type: Article

References (37)

1. Miniñ o AM, Murphy SL, Xu JQ, Kochanek KD. Deaths: Final Data for 2008. National Vital Statistics Reports; vol 59 no 10. Hyattsville, MD: National Center for Health Statistics. 2011.
2. Holguin F, Folch E, Redd SC, Mannino DM. Co-morbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128(4):2005-2011.
3. Ekstrom MP, Wagner P, Strom KE. Trends in cause-specifi c mortality in oxygen-dependent Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 2011; 183(8):1032-1036.
4. Schnell KM, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd CM. Th e prevalence of clinically-relevant co-morbid conditions in patients with COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulmon Med, in press.
5. Marin JM, Cote CG, Diaz O, Lisboa C, Casanova C, Lopez MV, Carrizo SJ, Pinto-Plata V, Dordelly LJ, Nekach H, Celli BR. Prognostic assessment in COPD: Health related quality of life and the BODE index. Respir Med 2011; 105(6):916-921.
6. Eskander A, Waddell TK, Faughnan ME, Chowdhury N, Singer LG. BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation. J Heart Lung Transplant 2011;2011 Dec; 30(12):1334-1341.
7. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto L, Antó JM. Chronic obstructive pulmonary disease stage and health-related quality of life. Th e Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997; 127(12):1072-1079.
8. van Manen JG, Bindels PJ, Dekker FW, Bottema BJ, van der Zee JS, Ijzermans CJ, Schadé E. Th e infl uence of COPD on health-related quality of life independent of the infl uence of co-morbidity. J Clin Epidemiol 2003; 56(12):1177-1184.
9. van Manen J, Bindels P, Decker F et al. Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir Med 2001; 95:496-504.
10. Wijnhoven HA, Kriegsman DM, Hesselink AE, de Haan M, Schellevis FG. Th e infl uence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med 2003; 97(5):468-475.
11. Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD-its impact on health service utilisation and quality of life, a community study. Age Ageing 2006; 35(1):33-37.
12. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011, http://www. cdc. gov/nchs/nhanes. htm.
13. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major co-morbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Th orax 2010; 65(11):956-962.
14. Weiss CO, Boyd CM, Yu Q, Wolff JL, Leff B. Patterns of prevalent major chronic disease among older adults in the United States. JAMA 2007; 298(10):1160-1162.
15. CDC. July 21, 2009. About the National Health and Nutrition Examination Survey. CDC website. Retrieved 4/12/11, from, http://www. cdc. gov/nchs/nhanes/about-nhanes. htm
16. September 29, 2010. Specifying weighting parameters. CDC website. Retrieved 4/12/11 from http://www. cdc. gov/nchs/tutorials/Nhanes/SurveyDesign/ Weighting/intro. htm.
17. NHANES Response Rates and CPS Totals. CDC website. Retreived 4/12/11. http://www. cdc. gov/nchs/nhanes/response-rates-CPS. htm.
18. CDC. Measuring healthy days: population assessment of healthrelated quality of life. Atlanta, GA: US Department of Health and Human Services, CDC; November 2000. Downloaded from: http://www. cdc. gov/hrqol/methods. htm on August 12, 2011.
19. StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
20. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within diff erent racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009; 169(2):236-248.
21. Zhang Y, Post WS, Dalal D, Blasco-Colmenares E, Tomaselli GF, Guallar E. Coff ee, Alcohol, Smoking, Physical Activity and QT Interval Duration: Results from the Th ird National Health and Nutrition Examination Survey. PLoS One 2011; 6(2):e17584.
22. Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalization for COPD. Chest 2002; 121:1441-1448.
23. Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW. Th e impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail 2009; 11(12):1182-1188.
24. Antonelli-Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2794-2800.
25. Ljubic S, Metelko Z, Car N, Roglic G, Drazic Z. Reduction of diff usion capacity for carbon monoxide in diabetic patients. Chest 1998; 114:1033-1035.
26. Guvener N, Tutuncu NB, Akcay S, Eyuboglu F, Gokcel A. Alveolar gas exchange in patients with type 2 diabetes mellitus. Endocr J 2003; 50:663-667.
27. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003; 123(5):1684-1692.
28. Simpson CF, Boyd CM, Carlson MC, Griswold ME, Guralnik JM, Fried LP. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc 2004; 52(1):123-127.
29. Barr RG, Herbstman J, Speizer FE, Camargo CA Jr. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol 2002; 155(10):965-971.
30. Radeos MS, Cydulka RK, Rowe BH, Barr RG, Clark S, Camargo CA Jr. Validation of self-reported chronic obstructive pulmonary disease among patients in the ED. Am J Emerg Med 2009; 27(2):191-196.
31. Freeman EJ, Colpe LJ, Strine TW, Dhingra S, McGuire LC, Elam-Evans LD, et al. Public health surveillance for mental health. Prev Chronic Dis 2010; 7(1):A17. http://www. cdc. gov/pcd/issues/2010/jan/09-0126. htm. Accessed 12/15/2011.
32. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med 2007; 22(11):1596-1602.
33. Trinh NH, Youn SJ, Sousa J, Regan S, Bedoya CA, Chang TE, Fava M, Yeung A. Using electronic medical records to determine the diagnosis of clinical depression. Int J Med Inform 2011; 80(7):533-540.
34. Rascon-Aguilar IE, Pamer M, Wludyka P, Cury J, Vega KJ. Poorly treated or unrecognized GERD reduces quality of life in patients with COPD. Dig Dis Sci 2011; 56(7):1976-1980.
35. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363(12):1128-1138.
36. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011. Available from: http://www. goldcopd. org/.
37. Tinetti ME, McAvay GJ, Chang SS, Newman AB, Fitzpatrick AL, Fried TR, Peduzzi PN. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc 2011; 59:1686-1691.